$2.43
-0.035-1.42%
Last update: Nov 10, 5:04 PM

The average analyst price target for Sana Biotechnology is $7.90, 233.3% above the current price. Of 10 analysts, 10 rate it Buy. Targets range from $5 to $15. The latest change came on Aug 14, 2026, when B of A Securities lowered its price target on Sana Biotechnology from $7 to $6 and kept a Buy rating.
Price Target Range — 11 Quarters
Analyst Consensus — 10 Analysts
Rating Trend — Last 9 Months